The role of α2β1 and α3β1 integrin receptors in the initial anchoring of MDA-MB-231 human breast cancer cells to cortical bone matrix

Biochemical and Biophysical Research Communications

Volumn 250, Issue 3, 1998, Pages 735-740

  Lundström, Åse ^a   Holmbom, Johanna ^a   Lindqvist, Christer ^a   Nordström, Tommy ^a  

^a ÅBO AKADEMI UNIVERSITY   (Finland)

Author keywords

Attachment; Bone; Breast; Cancer; Collagen; Integrin

Indexed keywords

ANTIBODY; CELL RECEPTOR; CELL SURFACE RECEPTOR; COLLAGEN TYPE 1; COLLAGENASE; INTEGRIN; INTEGRIN RECEPTOR; MONOCLONAL ANTIBODY; PROTEIN SUBUNIT; UNCLASSIFIED DRUG; COLLAGEN RECEPTOR; VERY LATE ACTIVATION ANTIGEN 3;

ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER CELL; CELL ADHESION; CONTROLLED STUDY; CORTICAL BONE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BONE MATRIX; BREAST TUMOR; CATTLE; CELL CULTURE; DRUG EFFECT; FEMALE; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BONE MATRIX; BREAST NEOPLASMS; CATTLE; CELL ADHESION; COLLAGENASES; FEMALE; HUMANS; INTEGRIN ALPHA3BETA1; INTEGRINS; RECEPTORS, COLLAGEN; TUMOR CELLS, CULTURED;

EID: 0032578360     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1998.9389     Document Type: Article

References (29)

1. Tubiana-Hulin M. Bone. 12:1991;S9-S10.
2. Galasko C. S. B. Bone Metastases. 1981;G. K. Hall, Boston. p. 49.
3. Yoneda T., Sasaki A., Mundy G. R. Breast Cancer Res. Treat. 32:1994;73-84.
4. Galasko C. S. B., Ch M. Clin. Orthop. and Rel. Res. 155:1981;269-285.
5. Ruoslahti E. J. Clin. Invest. 87:1991;1-5.
6. Hynes R. O. Cell. 69:1992;11-25.
7. Chan B. M. C., Matsuura N., Takada Y., Zetter B. R., Hemler M. E. Science. 251:1991;1600-1602.
8. Matsuura N., Puzon-McLaughlin W., Irie A., Morikawa Y., Kakudo K., Takada Y. Am J Pathol. 148:1996;55-61.
9. Nakai M., Mundy G. R., Williams P. J., Boyce B., Yoneda T. Cancer Res. 52:1992;5395-5399.
10. Sasaki A., Boyce B. F., Story B., Wright K. R., Chapman M., Boyce R., Mundy G. R., Yoneda Y. Cancer Res. 55:1995;3551-3557.
11. Mbalaviele G., Dunstan C. R., Sasaki A., Williams P. J., Mundy G. R., Yoneda T. Cancer Res. 56:1996;4063-4070.
12. Yoneda T., Sasaki A., Dunstan C., Williams P. J., Bauss F., DeClerck Y. A., Mundy G. R. J. Clin. Invest. 10:1997;2509-2517.
13. Van der Pluijm G., Vloedgraven H. J. M., Ivanov B., Robey F. A., Grzesik W. J., Robey P. G., Papapoulos S. E., Löwik C. W. M. Cancer Res. 56:1996;1948-1955.
14. Van der Pluijm G., Vloedgraven H., Van Beek E., Van der Wee-Pals L., Löwik C., Papapoulus S. J. Clin. Invest. 98:1996;698-705.
15. Nordström T., Knekt M., Nordström E., Lindqvist C. Bone. 22:1998;40S.
16. Cailleau R., Young R., Olive M., Reeves W. J. Jr. JNCI. 53:1974;661-674.
17. Biedler J. L., Helson L., Sprengler B. A. Cancer Res. 33:1973;2643-2652.
18. Kaighn M. E., Narayan K. S., Ohnuki Y., Lechner J. F., Jones L. W. Invest. Urol. 17:1979;16-23.
19. Schwenk H., Schneider U. Blut. 31:1975;299-306.
20. Van der Pluijm G., Vloedgraven H., Papapoulus S., Löwik C., Grzesik W., Kerr J., Robey P. G. Lab Invest. 77:1997;665-675.
21. Boissier S., Magnetto S., Frappart L., Cuzin B., Ebetino F. H., Delmas P. D., Clezardin P. Cancer Res. 57:1997;3890-3894.
22. Carter D. R. Clin. Orthop. 135:1978;192-217.
23. Shevrin D. H., Kukreja S. C., Ghosh L., Lad T. E. Clin. Exp. Metastasis. 6:1988;401-409.
24. Shevrin D. H., Gorny K. I., Rosol T. J., Kukreja S. C. The Prostate. 19:1991;149-154.
25. Kirchhofer D., Languino L. R., Ruoslahti E., Pierschbacher M. D. J. Biol. Chem. 265:1990;615-618.
26. Vihinen P., Riikonen T., Laine A., Heino J. Cell Growth. Differ. 7:1996;439-447.
27. Singer I. I., Scott S., Kawka D. W., Kazazis D. M., Gailit J., Ruoslahti E. J. Cell Biol. 106:1988;2171-2182.
28. Wayner E. A., Orlando R. A., Cheresh D. A. J. Cell Biol. 113:1991;919-929.
29. Hamilton R., Campbell F. R. Anat. Rec. 231:1991;218-224.